Alerts will be sent to your verified email
Verify EmailMEDICO
|
Medico Remedies
|
Shivalik Rasayan
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.93 % | 6.54 % | 6.92 % |
|
5yr average Equity Multiplier
|
2.07 | 1.82 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
1.49 | 0.44 | 0.55 |
|
5yr Avg Net Profit Margin
|
4.73 % | 7.94 % | 8.69 % |
|
Price to Book
|
4.44 | 0.56 | 1.13 |
|
P/E
|
25.52 | 27.89 | 32.13 |
|
5yr Avg Cash Conversion Cycle
|
53.33 Days | 100.7 Days | 49.75 Days |
|
Inventory Days
|
48.95 Days | 80.64 Days | 84.58 Days |
|
Days Receivable
|
129.15 Days | 107.04 Days | 139.4 Days |
|
Days Payable
|
124.28 Days | 166.18 Days | 264.75 Days |
|
5yr Average Interest Coverage Ratio
|
11.55 | 8.55 | 7.03 |
|
5yr Avg ROCE
|
20.03 % | 8.54 % | 10.34 % |
|
5yr Avg Operating Profit Margin
|
7.11 % | 17.6 % | 15.51 % |
|
5 yr average Debt to Equity
|
0.26 | 0.2 | 0.15 |
|
5yr CAGR Net Profit
|
31.26 % | -1.04 % | -11.57 % |
|
5yr Average Return on Assets
|
6.88 % | 3.57 % | 4.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.38 % | 47.37 % | 40.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-11.96 % | -2.95 % | -2.75 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medico Remedies
|
Shivalik Rasayan
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|